FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 301 through 325 of 325

BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES - SIC # 2836

Ticker Exchange Company Financial Reports SIC #
TRVI Nasdaq Trevi Therapeutics, Inc. 2836
TSBX Nasdaq Turnstone Biologics Corp. 2836
TSHA Nasdaq Taysha Gene Therapies, Inc. 2836
TVGN Nasdaq Tevogen Bio Holdings Inc. 2836
TWST Nasdaq Twist Bioscience Corporation 2836
TXG Nasdaq 10x Genomics, Inc. 2836
UNCY Nasdaq Unicycive Therapeutics, Inc. 2836
URGN Nasdaq UroGen Pharma Ltd. 2836
UTHR Nasdaq United Therapeutics Corporation 2836
VALN Nasdaq Valneva SE 2836
VERA Nasdaq Vera Therapeutics, Inc. 2836
VIVS Nasdaq VivoSim Labs, Inc. 2836
VRDN Nasdaq Viridian Therapeutics, Inc. 2836
VRTX Nasdaq Vertex Pharmaceuticals Incorporated 2836
VTRLY Over the counter Vitrolife AB (publ) 2836
XBIO Nasdaq Xenetic Biosciences, Inc. 2836
XCUR Nasdaq Exicure, Inc. 2836
XTNT NYSE American Xtant Medical Holdings, Inc. 2836
YMAB Nasdaq Y-mAbs Therapeutics, Inc. 2836
ZBIO Nasdaq Zenas BioPharma, Inc. 2836
ZLAB Nasdaq Zai Lab Limited 2836
ZNTL Nasdaq Zentalis Pharmaceuticals, Inc. 2836
ZTS New York Zoetis Inc. 2836
ZURA Nasdaq Zura Bio Limited 2836
ZYME Nasdaq Zymeworks Inc. 2836
Results 300 through 325 of 325